| Drug Type Small molecule drug | 
| Synonyms- | 
| Action antagonists, agonists | 
| Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | Belgium  | 24 Jul 2025 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | Czechia  | 24 Jul 2025 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | Netherlands  | 24 Jul 2025 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | Spain  | 24 Jul 2025 | |
| Asthma | Phase 1 | - | - | |
| Asthma | Phase 1 | - | - | |
| Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - | |
| Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - | 





